Form 4: Aurinia Director's Tax Withholding on RSU Vesting
Insider Transaction Report
Aurinia Pharmaceuticals director Craig A. Johnson reported the disposition of 6,039 common shares to cover tax obligations from restricted stock unit vesting.
Summary
- Craig A. Johnson, a Director of Aurinia Pharmaceuticals Inc. (AUPH), reported a transaction on November 21, 2025.
- 6,039 common shares were disposed of at a price of $15.68 per share.
- This disposition was to satisfy tax withholding obligations upon the vesting of restricted stock units.
- Following this transaction, Johnson beneficially owns 14,592 common shares directly.
Sentiment
Score: 5
Explanation: The transaction is a routine tax withholding event upon RSU vesting, which is a neutral event in terms of company performance or outlook. It reflects standard compensation practices.
Positives
- The transaction indicates the vesting of restricted stock units, which is a form of compensation for the director, suggesting continued alignment of interests.
Negatives
- A reduction in direct share ownership by 6,039 shares, although this is a standard procedure for tax withholding.
Future Outlook
No forward-looking statements or guidance are provided in this filing.
Industry Context
This is a routine insider transaction disclosure related to executive compensation and does not directly relate to broader industry trends or competitive landscape.
Comparison to Industry Standards
- The disposition of shares for tax withholding upon RSU vesting is a common and standard practice for executive compensation plans across various industries, aligning with typical corporate governance and compensation structures.
Related Party Transactions
- Disposition of 6,039 common shares by Director Craig A. Johnson to satisfy tax withholding obligations related to RSU vesting, valued at $15.68 per share.
Stakeholder Impact
- Shareholders: Minimal direct impact as this is a routine compensation-related transaction for a director.
- Employees: No direct impact mentioned.
- Customers: No direct impact mentioned.
- Suppliers: No direct impact mentioned.
- Creditors: No direct impact mentioned.
Key Dates
| Date | Description |
|---|---|
| 11/21/2025 | Date of transaction where shares were disposed of for tax withholding upon RSU vesting. |
| 11/24/2025 | Date the Form 4 was signed by Craig Johnson. |
Keywords
Aurinia Pharmaceuticals, AUPH, Craig Johnson, Form 4, Insider Transaction, Director, Share Disposition, Tax Withholding, Restricted Stock Units, RSU Vesting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.